PrivaseaAI (PRAI) fluctuated by 60.0% in 24 hours: Low liquidity and surging trading volume trigger turbulence
Bitget Pulse2026/04/12 16:02Volatility Brief
In the past 24 hours, PRAI price rebounded from a low of $0.002 to a high of $0.0032, currently at $0.00208, with a price fluctuation amplitude of 60.0%. The 24-hour trading volume is about $1.25 million, higher than usual, showing signs of net capital inflow but on a limited scale.
Analysis of Abnormal Fluctuations
- Sudden surge in trading volume: Trading volume rose to $1.25–1.84 million within 24 hours. In this low-liquidity market, price fluctuations were amplified, with the price surging from a low of $0.00178 to a high of $0.0032.
- No clear news or announcement as a driver: No official releases, large on-chain transfers, or coverage by mainstream media appeared in the past 24 hours. Market activity was mainly driven by speculative trading.
Market Views and Outlook
There is division among trading communities; some analysts see $0.0018 as a key support. If it holds, prices are expected to rise above $0.0025; otherwise, a pullback to $0.0016 is possible. Low liquidity risk is prominent, and short-term volatility may persist—pay close attention to changes in trading volume.
Note: This analysis is automatically generated by AI based on publicly available data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Stan Druckenmiller backs trade.xyz, ICE partnership targets US perpetual futures
Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours
Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.
Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare
On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.